ROS accumulation in RCC activates the NF-kB signaling pathway, pSTAT3, and G6PD, which regulate tumorigenesis-related genes and promote RCC oncogenic transformation. The gene discussed is NFKB1; the disease is renal cell adenocarcinoma.